TITLE

Colorectal Cancer in Patients Younger than 40 Years of Age

AUTHOR(S)
Keswani, Sundeep G.; Boyle, Michael J.; Maxwell IV, Johnathon P.; Mains, Lindsay; Wilks, Sauee M.; Hunt, John P.; O'Leary, J. Patrick
PUB. DATE
October 2002
SOURCE
American Surgeon;Oct2002, Vol. 68 Issue 10, p871
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Previous studies have suggested a poor outcome for patients presenting with colorectal cancer under the age of 40 years. This study was conducted to evaluate the outcomes of these patients during a 10-year period at the Medical Center of Louisiana in New Orleans. A retrospective study was designed to review all patients under the age of 40 with a diagnosis of colorectal cancer from January 1990 to December 2000. There were 664 patients presenting with colorectal cancer during the 10-year period; of these 24 presented for surgery under the age of 40. There were 17 male and seven female patients. The median age was 35 years (range 22-39). Eleven (44%) patients had a positive family history of colorectal cancer. Seven lesions were right sided, one transverse, eight left sided, and eight rectal. Histologically 20 lesions were typical adenocarcinomas and four were mucinous. Twelve were stage IV, six stage III, five stage II, and one stage I. Twenty-one patients underwent resection, six with stoma formation; three patients had stoma formation only for a total of nine stomas (38%). The mean operative duration was 3.3 ± 1.9 hours. The operative mortality was 4 per cent with a complication rate of 17 per cent. The eight rectal cancer patients received preoperative chemoradiation therapy (33%). Twelve (50%) patients with colon cancer received postoperative 5-fluorouracil-based chemotherapy. The mean survival for all patients was 24.7 ± 23.2 months. Estimated 5-year survival using Kaplan-Meier analysis was 30 per cent. We conclude that colorectal cancer patients less than 40 years of age present at an advanced stage and tend to have a positive family history. In general patients tolerate surgery well, with stoma formation in more than one-third. Long-term survival is as predicted for their advanced stage of presentation. The study highlights the need for early diagnosis in this patient group.
ACCESSION #
7745041

 

Related Articles

  • Continuing Medical Education Questions: July 2011. DeVault, Kenneth R.; Carey, Emily; Hanouneh, Ibrahim; Kane, Saul; Navaneethan, Udayakumar // American Journal of Gastroenterology;Jul2011, Vol. 106 Issue 7, p1207 

    A quiz concerning colonoscopy of elderly patients with colorectal cancer is presented.

  • The Prognostic Significance of Chromosome Abnormalities in Colon Tumors. Lubs, Herbert A.; Kotler, Stuart // Annals of Internal Medicine;Aug67, Vol. 67 Issue 2, p328 

    Provides information on a study that examined the clinical-cytogenetic correlations in patients with colon tumors. Methodology of the study; Results and discussion on the study.

  • Influence of stage at diagnosis on survival differences for rectal cancer in three European populations. Monnet, E; Faivre, J; Raymond, L; Garau, I // British Journal of Cancer;10/1/99, Vol. 81 Issue 3, p463 

    Important differences have recently been highlighted between European countries in the survival of colorectal cancer patients. As data on stage at diagnosis were available for rectal cancers in three European population-based registries (Geneva Switzerland; Côte d'Or, France; Mallorca,...

  • A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Kabat, G. C.; Miller, A. B.; Jain, M.; Rohan, T. E. // British Journal of Cancer;12/3/2007, Vol. 97 Issue 11, p1600 

    A correction to the article "A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women" that was published in the previous issue is presented.

  • Letter to the Editor: Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation. Yin, Peihao; Qiu, Yanyan; Li, Qi // International Journal of Colorectal Disease;May2013, Vol. 28 Issue 5, p733 

    A letter to the editor is presented in response to the article "Worse prognosis caused by anti-EGFR treatment in advanced colorectal cancer patients with KRAS mutation," by Peihao Yin, Yanyan Qiu and Qi Li, published in the previous issue of the periodical.

  • QuickStats.  // MMWR: Morbidity & Mortality Weekly Report;3/27/2015, Vol. 64 Issue 11, p310 

    A chart is presented that shows the mortality rates of U.S. people with colorectal cancer from 1999 to 2013.

  • Ziv-aflibercept yields encouraging results in metastatic colorectal cancer.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p26 

    The article reports on a study by Doctor Eric Van Cutsem, head of digestive oncology and professor of medicine at University Hospital Gasthuisberg in Leuven, Belgium, stating that the addition of ziv-aflibercept to infusional FOLFIRI improved survival in metastatic colorectal cancer patients.

  • Adverse Reaction Research.  // Reactions Weekly;3/13/2010, Issue 1292, p3 

    The article focuses on a study which examined the use of homozygous UGT1A1*28 genotype to predict grade 3 4 treatment-induced neutropenia in colorectal cancer patients receiving irinotecan.

  • The outcome of young colorectal cancer patients is controversial. Fu, Jian-Fei // Techniques in Coloproctology;Dec2013, Vol. 17 Issue 6, p671 

    A letter to the editor is presented in response to an article about patients with colorectal cancer.

  • Heparin-induced thrombocytopenia in a patient with colon cancer. Koul, Ajaz Nabi; Ahad, Ridwana // Indian Journal of Medical & Paediatric Oncology;Oct-Dec2013, Vol. 34 Issue 4, p336 

    A response from the authors of the article "heparin-induced thrombocytopenia (HIT) in a patient with colonic cancer" in the December 2012 issue is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics